Virtually There: Transitioning Your Genetics Clinic to Telehealth (Quickly)

Recent events have required limitation of non-urgent in-person appointments to slow the spread of covid-19. Despite the recognized value of genetic risk assessment, counseling and testing, many cases will not be considered urgent. Additionally, the population typically served by genetics providers may be at higher risk for infection and/or consequences of being infected.

In an environment of increasingly long wait lists, one option is to make the move to virtual care. Rapid changes in insurance coverage and billing codes, the availability of saliva collection kits for genetic testing, as well as improved access to multiple virtual platforms allow for new opportunities to transition to telehealth provision of genetic counseling services. This webinar will cover what to consider as you assess your current resources and readiness to provide telehealth and practical resources that will help you implement telehealth. Even if you have never provided telehealth before, you may find that you are "virtually there".

Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Stephanie Cohen, MS, CGC | Presenter

Genetic Counselor, Cancer Genetics Risk Assessment Program, St. Vincent Health

Stephanie Cohen is a licensed, board-certified genetic counselor in the Cancer Genetics Risk Assessment Program at Ascension St. Vincent in Indianapolis, IN. Stephanie has a strong interest in improving access to cancer genetic services and has worked to implement a collaborative process utilizing a network of genetic counselor extenders throughout the Ascension St. Vincent Health system across the state of Indiana. She is active in training genetic counseling students by serving as a clinical supervisor and research advisor. She is Chair of the Research, Quality and Outcomes Committee of the National Society of Genetic Counselors and has multiple publications in the field of cancer genetics and genetic counseling service delivery.

Lindsay Bailey, MS, CGC | Presenter

Genetic Counselor, Genomic Medicine Institute, Geisinger Health System

Lindsay Bailey is a certified and licensed genetic counselor at Geisinger Medical Center in Danville, Pennsylvania. She completed her genetic counseling graduate education at Virginia Commonwealth University in Richmond, Virginia. After graduation, she started her career at Geisinger Medical Center as a genetic counselor in maternal fetal medicine and research coordinator within the genomic medicine institute. In addition to maintaining a busy clinical practice, she participates in education for OBGYN residents and MFM fellows through lectures and other teaching opportunities. She also teaches graduate level clinical genetics for healthcare graduate students at a local university.

Greg Nogle | Presenter

Director, Market Access, Ambry Genetics

Mr. Nogle has had an extensive history within the market access field, and currently is the Director of Market Access for Ambry Genetics, a division of Konica Minolta Global Healthcare. In this role, he is responsible for integrating coding/coverage initiatives with CMS and Medicare contractors and driving reimbursement strategies for commercial and government payers. In addition, he leads coverage efforts aligned with clinical affairs to drive policy changes within molecular diagnostics. In his career, Greg held positions on the payor side, creating clinical and ancillary networks under risk and alternative payment models. He has also held leadership reimbursement positions in numerous industries, including medical device, therapeutics and diagnostics with such companies and HealthSouth, Roche Diagnostics and Insulet Corporation. He holds a B.S. from LSU where he focused on economics and history.

Emily Dalton, MS, CGC | Moderator

Director, Genomic Science Liaisons, Ambry Genetics

Emily Dalton is the Director of the Genomic Science Liaison team at Ambry Genetics, where she oversees a field-based team of clinical and technical experts in Ambry’s offerings. During her tenure at Ambry, Emily has presented at a number of domestic and international conferences and cultivated research collaborations with major academic medical centers. Prior to joining Ambry Emily spent four years as a cancer genetic counselor at the Dana-Farber Cancer Institute in Boston, MA and received her Master's in Genetic Counseling from the Boston University School of Medicine.